Active Pregnancy, Children & Inherited Conditions Diabetes, Hormones & Metabolism

Using genetics to understand causal mechanisms underlying adverse outcomes of obese pregnancies

In plain English

AI plain-English summary

More than one in five pregnant women in the UK are clinically obese, yet doctors cannot predict which of them will develop complications like gestational diabetes or preterm birth. Current studies struggle to untangle why a high maternal BMI leads to such different outcomes for different women. This research uses human genetics to trace causal pathways, rather than just observing associations. The key idea is that the fetus’s own genes may moderate how it responds to the mother’s obesity—influencing its growth, the timing of birth, and even the mother’s metabolic environment. The researcher will apply new genome-wide studies of placental weight and umbilical cord insulin to reveal these mechanisms. If successful, the work could allow clinicians to stratify pregnant women by actual risk, rather than treating all obese pregnancies the same. That would mean better-targeted antenatal care and advice, reducing the incidence of adverse outcomes without unnecessary interventions for low-risk women. This is fundamental science with a clear translational goal: turning genetic insight into practical, personalised pregnancy management.

View original technical description
More than 1 in 5 UK pregnant women are clinically obese, a condition associated with heterogeneous health outcomes for mother and baby. Only limited understanding of the associations (e.g. gestational diabetes and high birth weight, hypertension and preterm birth/low birth weight) has been possible in traditional observational studies due to complex interrelated exposures and outcomes. My research will use human genetics to dissect causal pathways and understand how a higher maternal BMI can lead to such diverse outcomes. I hypothesise that maternal effects on fetal growth and gestational duration are moderated by fetal genetics. My first aim is to understand how a fetus regulates its own growth and gestational duration in different maternal environments. We will apply results of new genome-wide association studies of placental weight and umbilical cord insulin to give mechanistic insights. My second aim is to understand how raised maternal BMI impacts gestational duration and growth, and my third aim is to examine whether fetal genetics can influence the maternal environment. By identifying causal mechanisms, this fellowship will be an advance towards better targeting of antenatal healthcare and advice to pregnant women, according to their level of risk to reduce the incidence of adverse pregnancy outcomes.

View the original record at the funder ↗

Researchers

Rachel Freathy (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Using genetics to understand how the maternal intrauterine environment influences fetal growth.
Biomarkers of materno-fetal health: role placental endocrine mediators in normal and obese pregnancies
Polygenic prediction of pre-eclampsia and characterisation of maternal and fetal genomic determinants of cardiovascular dysfunction in pregnancy
Exploring the transgenerational impacts of maternal surgical and pharmacological obesity management
Effects of maternal gestational adiposity on fetal development and perinatal, postnatal and next generation health.

Original classification

Senior Research Fellowship

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.